Femme et Homme
- | Pays : -
- | Organes : -
- | Spécialités : -
Extrait
To evaluate the efficacy and tolerability of intravenously administered azithromycin given as a 1.5 g single dose compared to 500 mg daily dose over a period of 3 days in patients suffering from community-acquired pneumonia. If azithromycin treatment administered intavenously as a 1.5 g dose can be proven therapeutically equivalent or not inferior to 500 mg administered intravenously over a period of 3 days, treatment of CAP patients can be optimised. This short regimen has the potential for enhancement of patient compliance and will lead to a reduction of costs because of minimisation of hospitalisation days. It even provides the possibility of outpatient treatment administration in patients with minor compliance.
Critère d'inclusion
- Community Aquired Pneumonia